Loading clinical trials...

UNKNOWNPhase 2NCT02095743

Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer

Adjuvant chemotherapy is frequently proposed to patients presenting early breast cancer, in case of high risk of recurrence (large tumors, node involvement, high grade…). Due to its toxicity toward ve...

Lead sponsor: Centre Henri Becquerel•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy

NCT07386444 · Early Stage Breast Carcinoma, Dyspnea

RECRUITING

Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

NCT05417867 · Chemotherapy-Related Nausea and/or Vomiting, Early Stage Breast Carcinoma, and more

COMPLETEDNA

Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy

NCT02212860 · Early Stage Breast Carcinoma

TERMINATEDPhase 1

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

NCT02876640 · Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 24, 2018Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment256

Start dateApr 2014

Last updatedJul 24, 2018

Condition

Early Stage Breast Carcinoma

Locations shown

Centre Henri Becquerel

Rouen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 24, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions